| MEDFX | WEDRX | MEDFX / WEDRX | |
| Total Expense Ratio | 1.06 | 0.65 | 163% |
| Annual Report Gross Expense Ratio | 1.07 | 1.02 | 105% |
| Fund Existence | 17 years | 4 years | - |
| Gain YTD | 10.341 | 14.077 | 73% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.63B | 68.5M | 11,136% |
| Annual Yield % from dividends | 5.09 | 6.32 | 81% |
| Returns for 1 year | 10.52 | 14.90 | 71% |
| Returns for 3 years | 34.57 | 46.49 | 74% |
| Returns for 5 years | 10.44 | N/A | - |
| Returns for 10 years | 46.79 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IYSYX | 19.07 | 0.17 | +0.90% |
| Macquarie Smid Cap Core Fund Class Y | |||
| BBGLX | 28.06 | 0.16 | +0.57% |
| Bridge Builder Large Cap Growth | |||
| ALARX | 55.68 | N/A | N/A |
| Alger Capital Appreciation Instl I | |||
| STDFX | 46.91 | N/A | N/A |
| Allspring Large Cap Growth Admin | |||
| LIFLX | 15.67 | N/A | N/A |
| Lord Abbett Focused Large Cap Value I | |||